These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 134897)
21. [Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results]. Andersen M; Bechsgaard P; Frederiksen J; Hansen DA; Jürgensen HJ; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL Ugeskr Laeger; 1979 Nov; 141(45):3083-6. PubMed ID: 43001 [No Abstract] [Full Text] [Related]
22. The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction. Jürgensen HJ; Frederiksen J; Andersen MP; Bechsgaard P; Hansen DA; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL Acta Med Scand Suppl; 1984; 680():18-26. PubMed ID: 6428169 [No Abstract] [Full Text] [Related]
23. Deaths and non-fatal reinfarctions during two years' follow-up. Wihelmsson C; Vedin A; Wilhelmsen L; Tibblin G; Werkö L; Wedel H Acta Med Scand Suppl; 1975; 575():19-24. PubMed ID: 1098398 [No Abstract] [Full Text] [Related]
24. Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation. Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S Med J Aust; 1975 Oct; 2(17):668-73. PubMed ID: 1107769 [TBL] [Abstract][Full Text] [Related]
25. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Causes of death and post-mortem findings with special reference to early deaths. Hansen DA; Jürgensen HJ; Pedersen-Bjergaard O Acta Med Scand Suppl; 1984; 680():50-8. PubMed ID: 6375281 [No Abstract] [Full Text] [Related]
26. Beta blockers after myocardial infarction--aspects on study design based on current knowledge. Vedin A; Wilhelmsson C Acta Med Scand Suppl; 1981; 651():227-33. PubMed ID: 6119877 [TBL] [Abstract][Full Text] [Related]
27. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study. Jürgensen HJ; Andersen MP; Bechsgaard P; Frederiksen J; Hansen DA; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL Acta Med Scand Suppl; 1984; 680():8-17. PubMed ID: 6375283 [No Abstract] [Full Text] [Related]
28. Use of alprenolol in acute cardiac arrhythmias. Lemberg L; Arcebal AG; Castellanos A; Slavin D Am J Cardiol; 1972 Jul; 30(1):77-81. PubMed ID: 4402503 [No Abstract] [Full Text] [Related]
29. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests. Hansen PF; Rasmussen PA; Nyberg G Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873 [No Abstract] [Full Text] [Related]
30. Pindolol and alprenolol in angina pectoris: a comparative clinical study. Frithz G; Nordgren L Curr Ther Res Clin Exp; 1975 Feb; 17(2):133-8. PubMed ID: 803426 [No Abstract] [Full Text] [Related]
31. Long-term effect of alprenolol as antihypertensive agent. Bengtsson C Acta Med Scand Suppl; 1974; 554():9-14. PubMed ID: 4593676 [No Abstract] [Full Text] [Related]
32. Long-term alprenolol treatment affects serum T4, T3 and rT3 in euthyroid patients with ischaemic heart disease. Perrild H; Pedersen F; Rasmussen SL; Jürgensen HJ; Skovsted L Acta Endocrinol (Copenh); 1984 Feb; 105(2):190-3. PubMed ID: 6364669 [TBL] [Abstract][Full Text] [Related]
33. Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course. Croft CH; Rude RE; Gustafson N; Stone PH; Poole WK; Roberts R; Strauss HW; Raabe DS; Thomas LJ; Jaffe AS Circulation; 1986 Jun; 73(6):1281-90. PubMed ID: 3009050 [TBL] [Abstract][Full Text] [Related]
34. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Background and aims of the study. Jürgensen HJ Acta Med Scand Suppl; 1984; 680():4-7. PubMed ID: 6375279 [No Abstract] [Full Text] [Related]
35. [Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison]. Bergstrand RH; Vedin JA; Wilhelmsson CE Lakartidningen; 1973 Aug; 70(33):2817-20. PubMed ID: 4597664 [No Abstract] [Full Text] [Related]
36. [Effect of alprenolol on the extent myocardial infarction assessed by serial determination of serum creatine kinase]. Jürgensen HJ; Frederiksen J; Hansen DA; Pedersen-Bjergaard O Ugeskr Laeger; 1979 Nov; 141(45):3089-91. PubMed ID: 392856 [No Abstract] [Full Text] [Related]
37. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol. Aubert A; Nyberg G; Slaastad R; Tjeldflaat L Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702 [TBL] [Abstract][Full Text] [Related]
38. Induction of diabetes and oral glucose tolerance tests during and after chronic beta-blockade. Vedin A; Wilhelmsson C; Björntorp P Acta Med Scand Suppl; 1975; 575():37-40. PubMed ID: 1098400 [No Abstract] [Full Text] [Related]
39. Effects of alprenolol and isosorbide dinitrate in angina pectoris. A comparative study with methodological considerations. Keyriläinen O; Nyberg G; Uusitalo AJ Acta Med Scand; 1973 Apr; 193(4):281-92. PubMed ID: 4197870 [No Abstract] [Full Text] [Related]
40. Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits. Dahlström U; Berglund U; Karlsson E Acta Med Scand; 1980; 207(3):167-71. PubMed ID: 6102838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]